BlackRock Inc. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIX and the CUSIP is 13739U203. A total of 12 filers reported holding CANCER GENETICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q4 2020$102,000
-32.9%
36,6650.0%0.00%
Q3 2020$152,000
+36.9%
36,6650.0%0.00%
Q2 2020$111,000
+9.9%
36,6650.0%0.00%
Q1 2020$101,000
-53.9%
36,665
-0.0%
0.00%
Q4 2019$219,00036,6660.00%
Other shareholders
CANCER GENETICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Mayo Clinic 444$184,0000.25%
Renaissance Technologies 193,401$803,0000.00%
UBS Group AG 558$2,0000.00%
OSAIC HOLDINGS, INC. 433$2,0000.00%
WELLS FARGO & COMPANY/MN 14$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
MORGAN STANLEY 37$00.00%
ACADIAN ASSET MANAGEMENT LLC 18,001$75,0000.00%
BlackRock Inc. 36,665$152,0000.00%
CAPTRUST FINANCIAL ADVISORS 50$00.00%
View complete list of CANCER GENETICS INC shareholders